Luspatercept-aamt

US Brand Name(s): Reblozyl

Use of Luspatercept-aamt in Cancer Treatment

Experts have authorized Luspatercept-aamt to treat the following conditions:

Myelodysplastic syndromes or myeloproliferative neoplasms of various kinds causes Anemia. Adults who require frequent red blood cell transfusions and whose anemia has not responded to or cannot be treated with an erythropoiesis-stimulating drug are given this medication.

Researchers are also researching Luspatercept-aamt for use in the treatment of various diseases.

Detailed scientific definition- Definition from the NCI Drug Dictionary 

Luspatercept-aamt  – MedlinePlus Information A summary of key facts regarding this medication in layman’s terms, which may contain the following:

Cautions about this medicine; what are its uses and how to use it; what you should tell your doctor before taking it; things you should know about it before using it; other drugs that might interact with it; and possible negative effects.

Experts frequently investigate drugs like Luspatercept-aamt to see whether they can treat or prevent conditions other than those with authorization. This patient information leaflet only covers authorized uses of the medications. However, much of the material might also apply to authorized uses under investigation.